CASI Pharmaceuticals Inc (CASI) — Strategic Asset Allocation Index
CASI Pharmaceuticals Inc (CASI) has a Strategic Asset Allocation Index of 92.7% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $1.72 Million) total $1.72 Million, measured against net assets of $1.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CASI net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
CASI Pharmaceuticals Inc Strategic Asset Allocation Index (2000–2024)
This chart shows how CASI Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2024. As of December 2024, the index stands at 92.7%, representing strategic assets of $1.72 Million against net assets of $1.85 Million USD. For live market cap and overall valuation, see CASI stock market capitalisation.
Annual Strategic Asset Allocation Index for CASI Pharmaceuticals Inc (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for CASI Pharmaceuticals Inc from 2000 to 2024, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CASI net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 92.7% | $1.72 Million | $- | $1.72 Million | $1.85 Million | ▲ +85.8 pp |
| 2023 | 7.0% | $1.68 Million | $- | $1.68 Million | $24.16 Million | ▼ -4.2 pp |
| 2022 | 11.2% | $7.46 Million | $- | $7.46 Million | $66.93 Million | ▼ -46.4 pp |
| 2021 | 57.5% | $62.12 Million | $22.00 Million | $40.13 Million | $107.96 Million | ▲ +18.7 pp |
| 2020 | 38.8% | $40.20 Million | $10.76 Million | $29.44 Million | $103.57 Million | ▲ +22.8 pp |
| 2019 | 16.0% | $15.02 Million | $985.00K | $14.04 Million | $93.67 Million | ▲ +14.4 pp |
| 2018 | 1.6% | $1.75 Million | $1.75 Million | $- | $109.46 Million | ▼ -1.1 pp |
| 2017 | 2.7% | $1.05 Million | $1.05 Million | $- | $38.54 Million | ▲ +1.6 pp |
| 2016 | 1.1% | $229.59K | $229.59K | $- | $20.78 Million | ▲ +0.6 pp |
| 2013 | 0.5% | $78.14K | $78.14K | $- | $14.94 Million | ▼ -0.1 pp |
| 2012 | 0.6% | $53.00K | $53.00K | $- | $8.24 Million | ▼ -0.3 pp |
| 2011 | 1.0% | $25.00K | $25.00K | $- | $2.53 Million | ▼ -1.0 pp |
| 2010 | 1.9% | $104.00K | $104.00K | $- | $5.33 Million | ▼ -2.5 pp |
| 2008 | 4.5% | $264.00K | $264.00K | $- | $5.92 Million | ▲ +2.1 pp |
| 2007 | 2.3% | $621.00K | $621.00K | $- | $26.90 Million | ▲ +0.5 pp |
| 2006 | 1.8% | $848.00K | $848.00K | $- | $46.98 Million | ▼ -1.3 pp |
| 2005 | 3.1% | $915.00K | $915.00K | $- | $29.39 Million | ▼ -0.1 pp |
| 2004 | 3.2% | $1.15 Million | $1.15 Million | $- | $35.72 Million | ▼ -2.5 pp |
| 2003 | 5.7% | $1.99 Million | $1.99 Million | $- | $34.88 Million | ▼ -24.3 pp |
| 2002 | 30.0% | $3.15 Million | $3.15 Million | $- | $10.51 Million | ▲ +12.0 pp |
| 2001 | 18.0% | $4.18 Million | $4.18 Million | $- | $23.21 Million | ▼ -6.0 pp |
| 2000 | 24.0% | $4.58 Million | $4.58 Million | $- | $19.06 Million | — |